NCT05475925 2026-03-05
A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas
Dren Bio
Phase 1/2 Recruiting
Clinical Trials
3 trialsNCT05141682 2026-03-03
Oral Azacitidine for the Treatment of Relapsed or Refractory T-cell Large Granular Lymphocytic Leukemia
Ohio State University Comprehensive Cancer Center
Phase 1/2 Active not recruiting
NCT05863234 2025-04-30
Safety Evaluation Study for Patients With Aggressive NK-cell Leukemia
Hiroshima University Hospital
Phase 1/2 Recruiting